| Alexis Noble Crawford, PHARMD, BCPS | |
|
9366 Colvincrest Dr, Mechanicsville, VA 23116-2909 | |
| (804) 675-5000 | |
| Not Available |
| Full Name | Alexis Noble Crawford |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 9366 Colvincrest Dr, Mechanicsville, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043561830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 0202209903 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexis Noble Crawford, PHARMD, BCPS 9366 Colvincrest Dr, Mechanicsville, VA 23116-2909 Ph: (804) 675-5000 | Alexis Noble Crawford, PHARMD, BCPS 9366 Colvincrest Dr, Mechanicsville, VA 23116-2909 Ph: (804) 675-5000 |
News Archive
Since the release of President George W. Bush's Emergency Plan for AIDS Relief, the U.S. global AIDS coordinator and former CEO of Eli Lilly, Randall Tobias, and other Bush administration officials have made public remarks that question the quality of generic antiretroviral drugs and undermine international quality standards set by the World Health Organization.
Allos Therapeutics, Inc. today announced that FOLOTYN (pralatrexate injection) is now available for commercial sale in the United States. The U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYN for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) on September 24, 2009. This indication is based on overall response rate.
Plutonium may be many times more dangerous than previously thought. The cancer risk from exposure inside the body could be 10 times higher than is allowed for in calculating international safety limits.
Ipsen today announced positive initial results from the double-blind phase III study of Dysport (abobotulinumtoxinA) in Adult Upper Limb spasticity. Regarding the primary endpoints, treatment with Dysport showed statistically significant response versus placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale.
Pepscan Therapeutics, the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals, Ireland. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target.
› Verified 7 days ago
Dr. David Paul Briere Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9351 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-569-8241 | |
Dr. Carissa Marie Biddle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9268 Chamberlayne Rd, Mechanicsville, VA 23116 Phone: 804-746-4347 Fax: 804-746-4972 | |
Thomas Alan Cale, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7039 Mechanicsville Tpke, Mechanicsville, VA 23111 Phone: 804-746-1965 | |
Samina Dolan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7235 Bell Creek Rd, Mechanicsville, VA 23111 Phone: 804-559-8831 | |
Dr. Jessica Ann Walker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9351 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-569-8241 | |
Dr. Maimuna Bruce, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7039 Mechanicsville Tpke, Mechanicsville, VA 23111 Phone: 757-343-9608 |